Browse > Article

Effect of protein transduction domain fused-bone morphogenetic protein-2 on bone regeneration in rat calvarial defects  

Um, Yoo-Jung (Department of Periodontology, Oral Science Research Center, College of Dentistry, Yonsei University)
Cho, Kyoo-Sung (Department of Periodontology, Oral Science Research Center, College of Dentistry, Yonsei University)
Kim, Chong-Kwan (Department of Periodontology, Oral Science Research Center, College of Dentistry, Yonsei University)
Choi, Seong-Ho (Department of Periodontology, Oral Science Research Center, College of Dentistry, Yonsei University)
Chai, Jung-Kiu (Department of Periodontology, Oral Science Research Center, College of Dentistry, Yonsei University)
Kim, Chang-Sung (Department of Periodontology, Oral Science Research Center, College of Dentistry, Yonsei University)
Publication Information
Journal of Periodontal and Implant Science / v.38, no.2, 2008 , pp. 153-162 More about this Journal
Abstract
Purpose: Recombining bone morphogenetic protein (BMP) is usually acquiredfrom high level animals. Though this method is effective, its high cost limits its use. The purpose of this study was to evaluate the effect of bone morphogenetic protein-2 with protein transduction domain (BMP-2/PTD;TATBMP-2) on bone regeneration. Rat calvarial defect model and osteoblastic differentiation model using MC3T3 cell were used for the purpose of the study. Materials and Methods: MC3T3 cells were cultured until they reached a confluence stage. The cells were treated with 0, 0.1, 1, 10, 100, 500 ng/ml of BMP-2/PTD for 21 days and at the end of the treatment, osteoblastic differentiation was evaluated usingvon Kossa staining. An 8mm, calvarial, critical-size osteotomy defect was created in each of 48 male Spraque-Dawley rats (weight $250{\sim}300\;g$). Three groups of 16 animals each received either BMP-2/PTD (0.05mg/ml) in a collagen carrier, collagen only, or negative surgical control. And each group was divided into 2 and 8 weeks healing intervals. The groups were evaluated by histologic analysis(8 animals/group/healing intervals) Result: In osteoblastic differentiation evaluation test, a stimulatory effect of BMP-2/PTD was observed in 10ng/ml of BMP-2/PTD with no observation of dose-dependent manner. The BMP-2/PTD group showed enhanced local bone formation in the rat calvarial defect at 2 weeks. New bone was observed at the defect margin and central area of the defect. However, new bone formation was observed only in 50% of animals used for 2weeks. In addition, there was no new bone formation observed at 8 weeks. Conclusion: The results of the present study indicated that BMP-2/PTD(TATBMP-2) have an positive effect on the bone formation in vitro and in vivo. However, further study should be conducted for the reproducibility of the outcomes.
Keywords
Bone Regeneration; bone morphogenetic protein;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Celeste AJ, Iannazzi JA, Taylor RC, et al. Identification of transforming growth factor-family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A 1990;87:9843-9847
2 Kim CS, Choi SH, Choi BK, et al. The effect of recombinant human bone morphogenetic protein-4 on the osteoblastic differentiation of mouse calvarial cells affected by Porphyromonas gingivalis. J Periodontol 2002;73:1126-1132   DOI   ScienceOn
3 Kingsley DM, Bland AE, Grubber JM, et al. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF superfamily. Cell 1992;71:399-410   DOI   ScienceOn
4 Solloway MJ, Dudley AT, Bikoff EK, et al. Mice lacking BMP-6 function. Dev Genet 1998;22:321-323   DOI   ScienceOn
5 Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 1990;87:2220-2224   DOI
6 Reddi AH. Bone Morphogenetic Proteins: From Basic Science to Clinical Applications. J Bone Joint Surg Am 2001;83:S1 - S6   DOI   ScienceOn
7 Griffith DL, Keck PC, Sampath TK, et al. Three- dimensional structure of recombinant human osteogenic protein 1 : Structural paradigm for the transforming growth factor superfamily. Proc Natl Acad Sci USA 1996;93:878-883
8 Ahn SH, Kim CS, Suk HJ, et al. Effect of Recombinant Human Bone Morphogenetic Protein- 4 with Carriers in Rat Calvarial Defects. J Periodontol 2003;74:787-797   DOI   ScienceOn
9 Jung SW, Kim NH, Yook JI, et al. Bone regenerative effects of recombinant human bone morphogentic protein-2 employed protein transduction domain. J Korean Acad Periodontol 2007;37:497-509   과학기술학회마을   DOI
10 Kim CS, Kim JI, Kim J, et al. Ectopic bone formation associated with recombinanthuman bone morphogenetic protein-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2004;19:1-7
11 King GN, Cochran DL. Factors that modulate the effect of bone morphogenetic protein-induced periodontal regeneration; a critical review. J Periodontol 2002;73:925-936   DOI   ScienceOn
12 Yasco AW, Lane JM, Fellinger EJ. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). J Bone Joint Surg Am 1992;74-A:659-671
13 Ford KG, Souberbielle BE, Darling D, Farzaneh F. Protein transduction: an alternative to genetic intervention? Gene therapy 2001;8:1-4   DOI
14 Leifert LA, Whitton JL. "Translocatory proteins" and "protein transduction domains": a critical analysis of their biological effects and the underlying mechanism. Mol Ther 2003;8:13-20   DOI   ScienceOn
15 Takakis DN, Koh A, Jin L, et al. Peri-implant bone regenerationusing recombinant human bone morphogenetic protein-2 in a canine model: A dose-response study. J Periodontal Res 2002;37:93-100   DOI   ScienceOn
16 Cook SD, Wolfe MW, Salkeld SL, Rueger DC. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 1995;77:734-750   DOI   PUBMED
17 Sampath TK, Maliakal JC, Hauschka PV, et al. Recombinant human osteo-genic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992;267:20352-20362   PUBMED
18 Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242:1528-1534   DOI
19 Barboza EP, Duarte ME, Geolas L, et al. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 2000;71:488-496   DOI   ScienceOn
20 Frankel AD, Pabo CO. Cellular uptake of the TAT protein from human immunodeficiency virus. Cell 1988;55:1189 -1193   DOI   ScienceOn
21 Choi SH, Kim CK, Cho KS, et al. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J Periodontol 2002;73:63-72   DOI   ScienceOn
22 Pang EK, Im SU, Kim CS, et al. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in rat calvarial defects. J Periodontol 2004;75:1364-1370   DOI   ScienceOn
23 Hong SJ, Kim CS, Jung UW, et al. Fibrin-Fibronectin Sealing System in Combination with -Tricalcium Phosphate as a Carrier for Recombinant Human Bone Morphogenetic Protein-2: Effects on Bone Formation in Rat Calvarial Defects. Biomaterials 2005;27:3810-3816   DOI   ScienceOn
24 Urist MR, Lietze A, Dawson E. Beta-tricalcium phosphate delivery system for bone morphogenetic protein. Clin Orthop 1984;187:277-280
25 Jena N, Martin-Seisdedos C, McCue P, et al. BMP7 null mutation in mice: Developmental defects in skeleton, kidney, and eye. Exp Cell Res 1997;230:28-37   DOI   ScienceOn
26 Cook SD, Salkeld SL, Patron LP. Bone defect healing with an osteogenic protein-1 device combined with carboxymethylcellulose. J Biomed Mater Res Appl Biomater 2005;75:137-145
27 Ozkaynak E, Rueger DC, Drier EA, et al. Op-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 1990;9:2085-2093   PUBMED
28 Frankel AD, Pabo CO. Cellular uptake of the TAT protein from human immunodeficiency virus. Cell 1988;55:1189 -1193   DOI   ScienceOn
29 Lindgren M, Halbrink M, Prochiantz A, Langel U. Cell penetrating peptides. Trends Pharmacol Sci 2000;21:99-103   DOI   ScienceOn
30 Fawell S, Seery J, Daikh Y, et al. TAT- mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 1994;91:664-668   DOI
31 Jehangir SW, Radu VS, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nature medicine 2004;10:311-315
32 Cook SD, Baffes GC, Wolfe MW, et al. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am 1994;176:827-838
33 Sandhu HS, Kanim LE, Kabo JM, et al. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 1996;21:2115-2122   DOI
34 Watson K, Edwards RJ. HIV-1-trans-activating(TAT) protein both a target and a tool in therapeutic approaches. Biochem Pharmacol 1999;58:1521-1528   DOI   ScienceOn
35 Han DK, Kim CS, Cho KS. Effect of a Fibrin-fibronectin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 2005;76:2216-2222   DOI   ScienceOn
36 Maurice Green, and Paul M. Loewenstein. Autonomous Functional Domains of Chemically Synthesized Human Immunodeficiency Virus Tat Trans-Activator Protein. Cell 1988;55:1179-1188   DOI   ScienceOn
37 Schwarze SR, Hruska KA, Dowdy SF. Protein transduction : unrestricted delivery into all cell? Trends cell Biol 2000;10:290-295   DOI   ScienceOn
38 Schwarze SR, Dowdy SF. In vivo protein transduction : intercellular delivery of biological active proteins. componds and DNA. Trends Pharmacol Sci 2000;21:45-48   DOI   ScienceOn
39 Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunion. Clin Orthop 1986;205:299-308
40 Urist MR. Bone: formation by autoinduction. Science 1965;150:893-899   DOI   ScienceOn
41 Wikesjo UM, Guglielmoni P, Promsudthi A, et al. Periodontal repair in dogs: effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 1999;26:392-400   DOI   ScienceOn
42 Nagahara H, Vocero-Akbani AM, Snyder EL, et al. Transduction of full- length TAT union proteins into mammalian cells: TAT -p27Kip1 induces cell migration. Nat Med 1998;4:1449-1452   DOI   ScienceOn
43 Hyun SJ, Choi SH, Chai JK, et al. The effect of recombinant human bone morphogenetic protein-2, 4 and 7 on bone formation in rat calvarial defects. J Periodontol 2005;76:1-8   DOI   ScienceOn